Despite Bubble Fears, Korean Biopharma Rally Has Room To Run
This article was originally published in PharmAsia News
Executive Summary
A slew of promising news on new drug development and robust exports by South Korean pharma firms, coupled with a global biotech rally, have fueled appetite for the country’s pharma and biotech stocks so far this year.